Clinical Aspects of Gut Microbiota in Hepatocellular Carcinoma Management

Jinghang Xu,Qiao Zhan,Yanan Fan,Emily Kwun Kwan Lo,Fangfei Zhang,Yanyan Yu,Hani El-Nezami,Zheng Zeng
DOI: https://doi.org/10.3390/pathogens10070782
IF: 3.7
2021-06-22
Pathogens
Abstract:Liver cancer, predominantly hepatocellular carcinoma (HCC), is the third leading cause of cancer-related deaths worldwide. Emerging data highlight the importance of gut homeostasis in the pathogenesis of HCC. Clinical and translational studies revealed the patterns of dysbiosis in HCC patients and their potential role for HCC diagnosis. Research on underlying mechanisms of dysbiosis in HCC development pointed out the direction for improving the treatment and prevention. Despite missing clinical studies, animal models showed that modulation of the gut microbiota by probiotics may become a new way to treat or prevent HCC development.
microbiology
What problem does this paper attempt to address?